Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 76420-494
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 76420-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Zolpidem 02)
This is a graph showing the plasma concentrations of Zolpidem in ng/mL over time (in hours). The graph compares the plasma concentration of 12.5 mg of zolpidem tartrate extended-release tablets with 10 mg of zolpidem tartrate immediate release. The X-axis represents the time in hours, and the Y-axis represents the ng/mL of zolpidem in the plasma.*
Principal Display Panel (6.25 mg Tablet Bottle Label)
Enovachem zzzs offers Zolpidem Tartrate ER Tablets in different quantities ranging from 30 to 100 tablets with different NDC codes. The tablets have a strength of 6.25 mg and come in USP formulation. The tablets should be stored at a controlled room temperature and kept out of reach of children. The manufacturer of the tablets is Cantour Pharmaceuticals Inc. Please note that some parts of the text are not clear due to errors.*
Principal Display Panel (12.5 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.